Advertisement

Index by Author

August 1992; 41 (8)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Adezati, L

    • Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose. Diabetes August 1992 41:1009-1015; doi:10.2337/diabetes.41.8.1009

  2. Avogaro, A

    • Ketone body metabolism in NIDDM. Effect of sulfonylurea treatment. Diabetes August 1992 41:968-974; doi:10.2337/diabetes.41.8.968

  3. Axelrod, L

    • Coordinate control of lipolysis by prostaglandin E2 and prostacyclin in rat adipose tissue. Diabetes August 1992 41:927-935; doi:10.2337/diabetes.41.8.927

B

  1. Barnett, A H

    • Susceptibility to IDDM in a Chinese population. Role of HLA class II alleles. Diabetes August 1992 41:914-919; doi:10.2337/diabetes.41.8.914

  2. Bellanti, J A

    • Poly I:C accelerates development of diabetes mellitus in diabetes-prone BB rat. Diabetes August 1992 41:1016-1021; doi:10.2337/diabetes.41.8.1016

  3. Bell, G I

    • Linkage analysis of maturity-onset diabetes of the young with microsatellite polymorphisms. No linkage to ADA or GLUT2 genes in two families. Diabetes August 1992 41:962-967; doi:10.2337/diabetes.41.8.962

  4. Boeri, D

    • Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose. Diabetes August 1992 41:1009-1015; doi:10.2337/diabetes.41.8.1009

  5. Brocco, E

    • Role of atrial natriuretic peptide in the pathogenesis of sodium retention in IDDM with and without glomerular hyperfiltration. Diabetes August 1992 41:936-945; doi:10.2337/diabetes.41.8.936

  6. Buzzetti, R

    • An explanation for the neutral effect of DR2 on IDDM susceptibility in central Italy. Diabetes August 1992 41:904-908; doi:10.2337/diabetes.41.8.904

C

  1. Cagliero, E

    • Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose. Diabetes August 1992 41:1009-1015; doi:10.2337/diabetes.41.8.1009

  2. Carraro, A

    • Role of atrial natriuretic peptide in the pathogenesis of sodium retention in IDDM with and without glomerular hyperfiltration. Diabetes August 1992 41:936-945; doi:10.2337/diabetes.41.8.936

  3. Cavan, D A

    • Susceptibility to IDDM in a Chinese population. Role of HLA class II alleles. Diabetes August 1992 41:914-919; doi:10.2337/diabetes.41.8.914

  4. Chatzipanteli, K

    • Coordinate control of lipolysis by prostaglandin E2 and prostacyclin in rat adipose tissue. Diabetes August 1992 41:927-935; doi:10.2337/diabetes.41.8.927

  5. Ciaraldi, T P

    • In vitro effects of amylin on carbohydrate metabolism in liver cells. Diabetes August 1992 41:975-981; doi:10.2337/diabetes.41.8.975

  6. Cipollina, M R

    • Role of atrial natriuretic peptide in the pathogenesis of sodium retention in IDDM with and without glomerular hyperfiltration. Diabetes August 1992 41:936-945; doi:10.2337/diabetes.41.8.936

  7. Cockram, C S

    • Susceptibility to IDDM in a Chinese population. Role of HLA class II alleles. Diabetes August 1992 41:914-919; doi:10.2337/diabetes.41.8.914

  8. Collier, A

    • Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes August 1992 41:909-913; doi:10.2337/diabetes.41.8.909

  9. Connors, M A

    • Phosphoinositide metabolism in the developing conceptus. Effects of hyperglycemia and scyllo-inositol in rat embryo culture. Diabetes August 1992 41:989-997; doi:10.2337/diabetes.41.8.989

  10. Corbett, J A

    • Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM. Diabetes August 1992 41:897-903; doi:10.2337/diabetes.41.8.897

  11. Costanzi, S

    • An explanation for the neutral effect of DR2 on IDDM susceptibility in central Italy. Diabetes August 1992 41:904-908; doi:10.2337/diabetes.41.8.904

D

  1. De Grazia, U

    • An explanation for the neutral effect of DR2 on IDDM susceptibility in central Italy. Diabetes August 1992 41:904-908; doi:10.2337/diabetes.41.8.904

  2. Del Prato, S

    • Ketone body metabolism in NIDDM. Effect of sulfonylurea treatment. Diabetes August 1992 41:968-974; doi:10.2337/diabetes.41.8.968

  3. Duner, E

    • Ketone body metabolism in NIDDM. Effect of sulfonylurea treatment. Diabetes August 1992 41:968-974; doi:10.2337/diabetes.41.8.968

E

  1. Ewel, C H

    • Poly I:C accelerates development of diabetes mellitus in diabetes-prone BB rat. Diabetes August 1992 41:1016-1021; doi:10.2337/diabetes.41.8.1016

  2. Ezaki, O

    • Exercise training increases glucose transporter content in skeletal muscles more efficiently from aged obese rats than young lean rats. Diabetes August 1992 41:920-926; doi:10.2337/diabetes.41.8.920

F

  1. Fioretto, P

    • Role of atrial natriuretic peptide in the pathogenesis of sodium retention in IDDM with and without glomerular hyperfiltration. Diabetes August 1992 41:936-945; doi:10.2337/diabetes.41.8.936

  2. Fletcher, J A

    • Susceptibility to IDDM in a Chinese population. Role of HLA class II alleles. Diabetes August 1992 41:914-919; doi:10.2337/diabetes.41.8.914

G

  1. Gefel, D

    • Insulinlike effects of zinc ion in vitro and in vivo. Preferential effects on desensitized adipocytes and induction of normoglycemia in streptozocin-induced rats. Diabetes August 1992 41:982-988; doi:10.2337/diabetes.41.8.982

  2. Giorato, C

    • Role of atrial natriuretic peptide in the pathogenesis of sodium retention in IDDM with and without glomerular hyperfiltration. Diabetes August 1992 41:936-945; doi:10.2337/diabetes.41.8.936

  3. Gnudi, L

    • Ketone body metabolism in NIDDM. Effect of sulfonylurea treatment. Diabetes August 1992 41:968-974; doi:10.2337/diabetes.41.8.968

  4. Goldberg, M

    • In vitro effects of amylin on carbohydrate metabolism in liver cells. Diabetes August 1992 41:975-981; doi:10.2337/diabetes.41.8.975

  5. Groth, C G

    • Improvement of nerve conduction in diabetic neuropathy. A follow-up study 4 yr after combined pancreatic and renal transplantation. Diabetes August 1992 41:946-951; doi:10.2337/diabetes.41.8.946

H

  1. Hattersley, A

    • Linkage analysis of maturity-onset diabetes of the young with microsatellite polymorphisms. No linkage to ADA or GLUT2 genes in two families. Diabetes August 1992 41:962-967; doi:10.2337/diabetes.41.8.962

  2. Hawkins, B R

    • Susceptibility to IDDM in a Chinese population. Role of HLA class II alleles. Diabetes August 1992 41:914-919; doi:10.2337/diabetes.41.8.914

  3. Higuchi, M

    • Exercise training increases glucose transporter content in skeletal muscles more efficiently from aged obese rats than young lean rats. Diabetes August 1992 41:920-926; doi:10.2337/diabetes.41.8.920

  4. Hirochika, R

    • Somatic gene therapy for diabetes with an immunological safety system for complete removal of transplanted cells. Diabetes August 1992 41:956-961; doi:10.2337/diabetes.41.8.956

  5. Howie, A J

    • Evidence for unique distribution of Kimmelstiel-Wilson nodules in glomeruli. Diabetes August 1992 41:952-955; doi:10.2337/diabetes.41.8.952

I

  1. Iannicola, C

    • An explanation for the neutral effect of DR2 on IDDM susceptibility in central Italy. Diabetes August 1992 41:904-908; doi:10.2337/diabetes.41.8.904

  2. Itakura, H

    • Exercise training increases glucose transporter content in skeletal muscles more efficiently from aged obese rats than young lean rats. Diabetes August 1992 41:920-926; doi:10.2337/diabetes.41.8.920

  3. Itakura, M

    • Somatic gene therapy for diabetes with an immunological safety system for complete removal of transplanted cells. Diabetes August 1992 41:956-961; doi:10.2337/diabetes.41.8.956

J

  1. Jacobs, K H

    • Susceptibility to IDDM in a Chinese population. Role of HLA class II alleles. Diabetes August 1992 41:914-919; doi:10.2337/diabetes.41.8.914

  2. Jenkins, D

    • Susceptibility to IDDM in a Chinese population. Role of HLA class II alleles. Diabetes August 1992 41:914-919; doi:10.2337/diabetes.41.8.914

K

  1. Karlsson, F A

    • Islet cell and thyrogastric antibodies in 633 consecutive 15- to 34-yr-old patients in the diabetes incidence study in Sweden. Diabetes August 1992 41:1022-1027; doi:10.2337/diabetes.41.8.1022

  2. Kawakami, Y

    • Somatic gene therapy for diabetes with an immunological safety system for complete removal of transplanted cells. Diabetes August 1992 41:956-961; doi:10.2337/diabetes.41.8.956

  3. Kawanaka, K

    • Exercise training increases glucose transporter content in skeletal muscles more efficiently from aged obese rats than young lean rats. Diabetes August 1992 41:920-926; doi:10.2337/diabetes.41.8.920

L

  1. Landin-Olsson, M

    • Islet cell and thyrogastric antibodies in 633 consecutive 15- to 34-yr-old patients in the diabetes incidence study in Sweden. Diabetes August 1992 41:1022-1027; doi:10.2337/diabetes.41.8.1022

  2. Leach, J P

    • Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes August 1992 41:909-913; doi:10.2337/diabetes.41.8.909

  3. Lernmark, A

    • Islet cell and thyrogastric antibodies in 633 consecutive 15- to 34-yr-old patients in the diabetes incidence study in Sweden. Diabetes August 1992 41:1022-1027; doi:10.2337/diabetes.41.8.1022

  4. Lorenzi, M

    • Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose. Diabetes August 1992 41:1009-1015; doi:10.2337/diabetes.41.8.1009

  5. Lowe, G D

    • Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes August 1992 41:909-913; doi:10.2337/diabetes.41.8.909

  6. Lo, Y M

    • Linkage analysis of maturity-onset diabetes of the young with microsatellite polymorphisms. No linkage to ADA or GLUT2 genes in two families. Diabetes August 1992 41:962-967; doi:10.2337/diabetes.41.8.962

M

  1. Maiello, M

    • Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose. Diabetes August 1992 41:1009-1015; doi:10.2337/diabetes.41.8.1009

  2. Mantero, F

    • Role of atrial natriuretic peptide in the pathogenesis of sodium retention in IDDM with and without glomerular hyperfiltration. Diabetes August 1992 41:936-945; doi:10.2337/diabetes.41.8.936

  3. Maran, A

    • Ketone body metabolism in NIDDM. Effect of sulfonylurea treatment. Diabetes August 1992 41:968-974; doi:10.2337/diabetes.41.8.968

  4. McDaniel, M L

    • Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM. Diabetes August 1992 41:897-903; doi:10.2337/diabetes.41.8.897

  5. Metzger, B E

    • Phosphoinositide metabolism in the developing conceptus. Effects of hyperglycemia and scyllo-inositol in rat embryo culture. Diabetes August 1992 41:989-997; doi:10.2337/diabetes.41.8.989

  6. Mijovic, C H

    • Susceptibility to IDDM in a Chinese population. Role of HLA class II alleles. Diabetes August 1992 41:914-919; doi:10.2337/diabetes.41.8.914

  7. Morocutti, A

    • Role of atrial natriuretic peptide in the pathogenesis of sodium retention in IDDM with and without glomerular hyperfiltration. Diabetes August 1992 41:936-945; doi:10.2337/diabetes.41.8.936

N

  1. Nagata, M

    • Studies on autoimmunity for T-cell-mediated beta-cell destruction. Distinct difference in beta-cell destruction between CD4+ and CD8+ T-cell clones derived from lymphocytes infiltrating the islets of NOD mice. Diabetes August 1992 41:998-1008; doi:10.2337/diabetes.41.8.998

  2. Nakatsuka, H

    • Exercise training increases glucose transporter content in skeletal muscles more efficiently from aged obese rats than young lean rats. Diabetes August 1992 41:920-926; doi:10.2337/diabetes.41.8.920

  3. Nakauchi, H

    • Somatic gene therapy for diabetes with an immunological safety system for complete removal of transplanted cells. Diabetes August 1992 41:956-961; doi:10.2337/diabetes.41.8.956

  4. Nerup, J

    • Linkage analysis of maturity-onset diabetes of the young with microsatellite polymorphisms. No linkage to ADA or GLUT2 genes in two families. Diabetes August 1992 41:962-967; doi:10.2337/diabetes.41.8.962

  5. Newbold, K M

    • Evidence for unique distribution of Kimmelstiel-Wilson nodules in glomeruli. Diabetes August 1992 41:952-955; doi:10.2337/diabetes.41.8.952

  6. Nistico, L

    • An explanation for the neutral effect of DR2 on IDDM susceptibility in central Italy. Diabetes August 1992 41:904-908; doi:10.2337/diabetes.41.8.904

  7. Nosadini, R

    • Ketone body metabolism in NIDDM. Effect of sulfonylurea treatment. Diabetes August 1992 41:968-974; doi:10.2337/diabetes.41.8.968

O

  1. Odetti, P

    • Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose. Diabetes August 1992 41:1009-1015; doi:10.2337/diabetes.41.8.1009

  2. Odom, R

    • In vitro effects of amylin on carbohydrate metabolism in liver cells. Diabetes August 1992 41:975-981; doi:10.2337/diabetes.41.8.975

  3. Opocher, G

    • Role of atrial natriuretic peptide in the pathogenesis of sodium retention in IDDM with and without glomerular hyperfiltration. Diabetes August 1992 41:936-945; doi:10.2337/diabetes.41.8.936

P

  1. Patel, P

    • Linkage analysis of maturity-onset diabetes of the young with microsatellite polymorphisms. No linkage to ADA or GLUT2 genes in two families. Diabetes August 1992 41:962-967; doi:10.2337/diabetes.41.8.962

  2. Paterson, J R

    • Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes August 1992 41:909-913; doi:10.2337/diabetes.41.8.909

  3. Penny, M A

    • Susceptibility to IDDM in a Chinese population. Role of HLA class II alleles. Diabetes August 1992 41:914-919; doi:10.2337/diabetes.41.8.914

  4. Persson, A

    • Improvement of nerve conduction in diabetic neuropathy. A follow-up study 4 yr after combined pancreatic and renal transplantation. Diabetes August 1992 41:946-951; doi:10.2337/diabetes.41.8.946

  5. Podesta, F

    • Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose. Diabetes August 1992 41:1009-1015; doi:10.2337/diabetes.41.8.1009

R

  1. Riccio, A

    • Ketone body metabolism in NIDDM. Effect of sulfonylurea treatment. Diabetes August 1992 41:968-974; doi:10.2337/diabetes.41.8.968

  2. Rudolph, S

    • Coordinate control of lipolysis by prostaglandin E2 and prostacyclin in rat adipose tissue. Diabetes August 1992 41:927-935; doi:10.2337/diabetes.41.8.927

  3. Rumley, A

    • Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes August 1992 41:909-913; doi:10.2337/diabetes.41.8.909

  4. Rumley, A G

    • Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes August 1992 41:909-913; doi:10.2337/diabetes.41.8.909

S

  1. Sacerdoti, D

    • Role of atrial natriuretic peptide in the pathogenesis of sodium retention in IDDM with and without glomerular hyperfiltration. Diabetes August 1992 41:936-945; doi:10.2337/diabetes.41.8.936

  2. Sambataro, M

    • Role of atrial natriuretic peptide in the pathogenesis of sodium retention in IDDM with and without glomerular hyperfiltration. Diabetes August 1992 41:936-945; doi:10.2337/diabetes.41.8.936

  3. Sandison, A

    • Evidence for unique distribution of Kimmelstiel-Wilson nodules in glomeruli. Diabetes August 1992 41:952-955; doi:10.2337/diabetes.41.8.952

  4. Shechter, Y

    • Insulinlike effects of zinc ion in vitro and in vivo. Preferential effects on desensitized adipocytes and induction of normoglycemia in streptozocin-induced rats. Diabetes August 1992 41:982-988; doi:10.2337/diabetes.41.8.982

  5. Shisheva, A

    • Insulinlike effects of zinc ion in vitro and in vivo. Preferential effects on desensitized adipocytes and induction of normoglycemia in streptozocin-induced rats. Diabetes August 1992 41:982-988; doi:10.2337/diabetes.41.8.982

  6. Small, M

    • Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes August 1992 41:909-913; doi:10.2337/diabetes.41.8.909

  7. Sobel, D O

    • Poly I:C accelerates development of diabetes mellitus in diabetes-prone BB rat. Diabetes August 1992 41:1016-1021; doi:10.2337/diabetes.41.8.1016

  8. Solders, G

    • Improvement of nerve conduction in diabetic neuropathy. A follow-up study 4 yr after combined pancreatic and renal transplantation. Diabetes August 1992 41:946-951; doi:10.2337/diabetes.41.8.946

  9. Sorrentino, R

    • An explanation for the neutral effect of DR2 on IDDM susceptibility in central Italy. Diabetes August 1992 41:904-908; doi:10.2337/diabetes.41.8.904

  10. Stolpe, M

    • In vitro effects of amylin on carbohydrate metabolism in liver cells. Diabetes August 1992 41:975-981; doi:10.2337/diabetes.41.8.975

  11. Strieleman, P J

    • Phosphoinositide metabolism in the developing conceptus. Effects of hyperglycemia and scyllo-inositol in rat embryo culture. Diabetes August 1992 41:989-997; doi:10.2337/diabetes.41.8.989

  12. Sundkvist, G

    • Islet cell and thyrogastric antibodies in 633 consecutive 15- to 34-yr-old patients in the diabetes incidence study in Sweden. Diabetes August 1992 41:1022-1027; doi:10.2337/diabetes.41.8.1022

T

  1. Tiengo, A

    • Ketone body metabolism in NIDDM. Effect of sulfonylurea treatment. Diabetes August 1992 41:968-974; doi:10.2337/diabetes.41.8.968

  2. Tosi, R

    • An explanation for the neutral effect of DR2 on IDDM susceptibility in central Italy. Diabetes August 1992 41:904-908; doi:10.2337/diabetes.41.8.904

  3. Turner, R C

    • Linkage analysis of maturity-onset diabetes of the young with microsatellite polymorphisms. No linkage to ADA or GLUT2 genes in two families. Diabetes August 1992 41:962-967; doi:10.2337/diabetes.41.8.962

  4. Tybjaerg-Hansen, A

    • Linkage analysis of maturity-onset diabetes of the young with microsatellite polymorphisms. No linkage to ADA or GLUT2 genes in two families. Diabetes August 1992 41:962-967; doi:10.2337/diabetes.41.8.962

  5. Tydén, G

    • Improvement of nerve conduction in diabetic neuropathy. A follow-up study 4 yr after combined pancreatic and renal transplantation. Diabetes August 1992 41:946-951; doi:10.2337/diabetes.41.8.946

V

  1. Valerio, A

    • Ketone body metabolism in NIDDM. Effect of sulfonylurea treatment. Diabetes August 1992 41:968-974; doi:10.2337/diabetes.41.8.968

  2. Vichi, M

    • Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose. Diabetes August 1992 41:1009-1015; doi:10.2337/diabetes.41.8.1009

W

  1. Wainscoat, J S

    • Linkage analysis of maturity-onset diabetes of the young with microsatellite polymorphisms. No linkage to ADA or GLUT2 genes in two families. Diabetes August 1992 41:962-967; doi:10.2337/diabetes.41.8.962

Y

  1. Yamaoka, T

    • Somatic gene therapy for diabetes with an immunological safety system for complete removal of transplanted cells. Diabetes August 1992 41:956-961; doi:10.2337/diabetes.41.8.956

  2. Yamashita, K

    • Somatic gene therapy for diabetes with an immunological safety system for complete removal of transplanted cells. Diabetes August 1992 41:956-961; doi:10.2337/diabetes.41.8.956

  3. Yeung, V T

    • Susceptibility to IDDM in a Chinese population. Role of HLA class II alleles. Diabetes August 1992 41:914-919; doi:10.2337/diabetes.41.8.914

  4. Yoon, J W

    • Studies on autoimmunity for T-cell-mediated beta-cell destruction. Distinct difference in beta-cell destruction between CD4+ and CD8+ T-cell clones derived from lymphocytes infiltrating the islets of NOD mice. Diabetes August 1992 41:998-1008; doi:10.2337/diabetes.41.8.998

Z

  1. Zeligs, B J

    • Poly I:C accelerates development of diabetes mellitus in diabetes-prone BB rat. Diabetes August 1992 41:1016-1021; doi:10.2337/diabetes.41.8.1016

  2. Zolli, M

    • Ketone body metabolism in NIDDM. Effect of sulfonylurea treatment. Diabetes August 1992 41:968-974; doi:10.2337/diabetes.41.8.968

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement